Clinical trials developed in India vaccine against coronavirus Covaxin started at the all India Institute of medical Sciences (AIIMS) in Delhi. 24 Jul the first dose was administered 30-year-old resident of the capital, writes the Times of India , citing PTI.
Volunteer for two hours kept under observation in the hospital. Snapshot of side effects in volunteers was not observed, but it would control for seven days.
First Indian vaccine used inactivated version of the spike protein of SARS-CoV-2, that should cause a reaction of the immune system in antibody production. The potential vaccine produced in Hyderabad-based company Bharat Biotech.
Initially, volunteers will be administered small doses of the drug. If you find that it is safe, the next group, the dosage will increase.
A total of more than 1,800 volunteers have registered to participate in clinical research in AIIMS.
Seven Indian companies are working to create an effective vaccine against the coronavirus.
According to data from Johns Hopkins University, India ranks third in the world in the number of infected people (1 385 685), and died 32 063 citizen of the country.
Flash coronavirus infection began at the end of 2019 in China. March 11, 2020, the world health organization declared the spread of the coronavirus pandemic.
According to who, currently about 160 test vaccine against the coronavirus SARS-COV-2/COVID-19 worldwide, more than 20 of them are in the final stages.